[go: up one dir, main page]

SE0202959D0 - Peptide-Base passive immunization therapy for the treatment of atherosclerosis - Google Patents

Peptide-Base passive immunization therapy for the treatment of atherosclerosis

Info

Publication number
SE0202959D0
SE0202959D0 SE0202959A SE0202959A SE0202959D0 SE 0202959 D0 SE0202959 D0 SE 0202959D0 SE 0202959 A SE0202959 A SE 0202959A SE 0202959 A SE0202959 A SE 0202959A SE 0202959 D0 SE0202959 D0 SE 0202959D0
Authority
SE
Sweden
Prior art keywords
passive immunization
atherosclerosis
treatment
peptide
immunization therapy
Prior art date
Application number
SE0202959A
Other languages
Swedish (sv)
Inventor
Jenny Bengtsson
Leif Strandberg
Roland Carlsson
Jan Nilsson
Original Assignee
Forskarpatent I Syd Ab Ideon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forskarpatent I Syd Ab Ideon filed Critical Forskarpatent I Syd Ab Ideon
Priority to SE0202959A priority Critical patent/SE0202959D0/en
Publication of SE0202959D0 publication Critical patent/SE0202959D0/en
Priority to SE0302312A priority patent/SE0302312D0/en
Priority to AU2003263712A priority patent/AU2003263712A1/en
Priority to PCT/SE2003/001469 priority patent/WO2004030698A1/en
Priority to TW092126462A priority patent/TWI299666B/en
Priority to TW097111600A priority patent/TW200835517A/en
Priority to US10/679,032 priority patent/US7468183B2/en
Priority to EEP200500012A priority patent/EE200500012A/en
Priority to PT03748843T priority patent/PT1545609E/en
Priority to DE60336068T priority patent/DE60336068D1/en
Priority to AT03748843T priority patent/ATE498407T1/en
Priority to EP10075394A priority patent/EP2361633A1/en
Priority to PL376964A priority patent/PL376964A1/en
Priority to JP2005500961A priority patent/JP2006506450A/en
Priority to CA002500895A priority patent/CA2500895A1/en
Priority to CN200380104103.2A priority patent/CN1717251B/en
Priority to RU2005113235/15A priority patent/RU2322260C2/en
Priority to CN2010101282346A priority patent/CN102319429A/en
Priority to SI200331982T priority patent/SI1545609T1/en
Priority to EP10075393A priority patent/EP2359848A1/en
Priority to ES03748843T priority patent/ES2387423T3/en
Priority to AU2003267905A priority patent/AU2003267905B2/en
Priority to DK03748843.4T priority patent/DK1545609T3/en
Priority to CN2010101282350A priority patent/CN102172400A/en
Priority to EP03748843A priority patent/EP1545609B1/en
Priority to CN2011102300859A priority patent/CN102380097A/en
Priority to PCT/SE2003/001547 priority patent/WO2004030607A2/en
Priority to BR0315042-9A priority patent/BR0315042A/en
Priority to US11/323,123 priority patent/US7601353B2/en
Priority to HK06107155.0A priority patent/HK1087018A1/en
Priority to US11/612,591 priority patent/US20080008702A1/en
Priority to US11/928,221 priority patent/US7521046B2/en
Priority to RU2007140978/15A priority patent/RU2007140978A/en
Priority to US12/258,745 priority patent/US8114966B2/en
Priority to AU2009201260A priority patent/AU2009201260B2/en
Priority to JP2010001796A priority patent/JP2010104375A/en
Priority to JP2010001795A priority patent/JP2010104374A/en
Priority to JP2010001794A priority patent/JP2010136721A/en
Priority to JP2010141960A priority patent/JP2010222378A/en
Priority to CY20111100305T priority patent/CY1112229T1/en
Priority to US13/272,297 priority patent/US20120070426A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention relates to passive immunization for treating or preventing atherosclerosis using a recombinant human antibody directed towards at least one oxidized fragment of apolipoprotein B in the manufacture of a pharmaceutical composition for therapeutical or prophylactical treatment of atherosclerosis by means of passive immunization, as well as method for preparing such antibodies, and a method for treating a mammal, preferably a human using such an antibody to provide for passive immunization.
SE0202959A 2002-10-04 2002-10-04 Peptide-Base passive immunization therapy for the treatment of atherosclerosis SE0202959D0 (en)

Priority Applications (41)

Application Number Priority Date Filing Date Title
SE0202959A SE0202959D0 (en) 2002-10-04 2002-10-04 Peptide-Base passive immunization therapy for the treatment of atherosclerosis
SE0302312A SE0302312D0 (en) 2002-10-04 2003-08-27 Peptide-based passive immunization therapy for the treatment of atherosclerosis
AU2003263712A AU2003263712A1 (en) 2002-10-04 2003-09-22 Peptide-based passive immunization therapy for treatment of atherosclerosis
PCT/SE2003/001469 WO2004030698A1 (en) 2002-10-04 2003-09-22 Peptide-based passive immunization therapy for treatment of atherosclerosis
TW092126462A TWI299666B (en) 2002-10-04 2003-09-25 Peptide-based passive immunization therapy for treatment of atherosclerosis
TW097111600A TW200835517A (en) 2002-10-04 2003-09-25 Peptide-based passive immunization therapy for treatment of atherosclerosis
US10/679,032 US7468183B2 (en) 2002-10-04 2003-10-03 Antibody immunization therapy for treatment of atherosclerosis
BR0315042-9A BR0315042A (en) 2002-10-04 2003-10-06 Therapy for the treatment of atherosclerosis based on passive peptide immunization
SI200331982T SI1545609T1 (en) 2002-10-04 2003-10-06 Antibodies directed against oxidised apolipoprotein B
EP03748843A EP1545609B1 (en) 2002-10-04 2003-10-06 Antibodies directed against oxidised apolipoprotein B
DE60336068T DE60336068D1 (en) 2002-10-04 2003-10-06 Antibodies directed against oxidized apolipoprotein B
AT03748843T ATE498407T1 (en) 2002-10-04 2003-10-06 ANTIBODIES DIRECTED AGAINST OXIDATED APOLIPOPROTEIN B
EP10075394A EP2361633A1 (en) 2002-10-04 2003-10-06 Peptide-based passive immunization therapy for treatment of atherosclerosis
PL376964A PL376964A1 (en) 2002-10-04 2003-10-06 Peptide-based passive immunization therapy for treatment of atherosclerosis
JP2005500961A JP2006506450A (en) 2002-10-04 2003-10-06 Peptide-based passive immunotherapy for the treatment of atherosclerosis
CA002500895A CA2500895A1 (en) 2002-10-04 2003-10-06 Peptide-based passive immunization therapy for treatment of atherosclerosis
CN200380104103.2A CN1717251B (en) 2002-10-04 2003-10-06 Peptide-based passive immunization therapy for treatment of atherosclerosis
RU2005113235/15A RU2322260C2 (en) 2002-10-04 2003-10-06 Passive immunization peptides-based therapy for treating atherosclerosis
CN2010101282346A CN102319429A (en) 2002-10-04 2003-10-06 Be used to treat atherosclerotic peptide-based passive immunization therapy
EEP200500012A EE200500012A (en) 2002-10-04 2003-10-06 Peptide-based passive immunotherapy for the treatment of atherosclerosis
EP10075393A EP2359848A1 (en) 2002-10-04 2003-10-06 Peptide-based passive immunization therapy for treatment of atherosclerosis
ES03748843T ES2387423T3 (en) 2002-10-04 2003-10-06 DIRECTED ANTIBODIES AGAINST OXIDATED APOLIPROTEIN B
AU2003267905A AU2003267905B2 (en) 2002-10-04 2003-10-06 Peptide-based passive immunization therapy for treatment of atherosclerosis
DK03748843.4T DK1545609T3 (en) 2002-10-04 2003-10-06 Antibodies directed to oxidized apolipoprotein B
CN2010101282350A CN102172400A (en) 2002-10-04 2003-10-06 Peptide-based passive immunization therapy for treating atherosclerosis
PT03748843T PT1545609E (en) 2002-10-04 2003-10-06 Antibodies directed against oxidised apolipoprotein b
CN2011102300859A CN102380097A (en) 2002-10-04 2003-10-06 Peptide-based passive immunization therapy for treatment of atherosclerosis
PCT/SE2003/001547 WO2004030607A2 (en) 2002-10-04 2003-10-06 Peptide-based passive immunization therapy for treatment of atherosclerosis
US11/323,123 US7601353B2 (en) 2002-10-04 2005-12-30 Peptide-based passive immunization therapy for treatment of atherosclerosis
HK06107155.0A HK1087018A1 (en) 2002-10-04 2006-06-23 Peptide-based passive immunization therapy for treatment of atherosclerosis
US11/612,591 US20080008702A1 (en) 2002-10-04 2006-12-19 Antibody immunization therapy for treatment of atherosclerosis
US11/928,221 US7521046B2 (en) 2002-10-04 2007-10-30 Antibody immunization therapy for treatment of atherosclerosis
RU2007140978/15A RU2007140978A (en) 2002-10-04 2007-11-02 PASSIVE IMMUNIZATION THERAPY BASED ON PEPTIDES FOR THE TREATMENT OF ATHEROSCLEROSIS
US12/258,745 US8114966B2 (en) 2002-10-04 2008-10-27 Peptide-based passive immunization therapy for treatment of atherosclerosis
AU2009201260A AU2009201260B2 (en) 2002-10-04 2009-03-31 Peptide-based passive immunization therapy for treatment of atherosclerosis
JP2010001796A JP2010104375A (en) 2002-10-04 2010-01-07 Peptide-based passive immunization therapy for treatment of atherosclerosis
JP2010001794A JP2010136721A (en) 2002-10-04 2010-01-07 Peptide-based passive immunization therapy for treatment of atherosclerosis
JP2010001795A JP2010104374A (en) 2002-10-04 2010-01-07 Peptide-based passive immunization therapy for treatment of atherosclerosis
JP2010141960A JP2010222378A (en) 2002-10-04 2010-06-22 Peptide-based passive immunization therapy for treatment of atherosclerosis
CY20111100305T CY1112229T1 (en) 2002-10-04 2011-03-21 DIRECTIONS GUIDED AGAINST OXIDATED SELF-PROTEIN B
US13/272,297 US20120070426A1 (en) 2002-10-04 2011-10-13 Peptide-based passive immunization therapy for the treatment of atherosclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0202959A SE0202959D0 (en) 2002-10-04 2002-10-04 Peptide-Base passive immunization therapy for the treatment of atherosclerosis

Publications (1)

Publication Number Publication Date
SE0202959D0 true SE0202959D0 (en) 2002-10-04

Family

ID=20289196

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0202959A SE0202959D0 (en) 2002-10-04 2002-10-04 Peptide-Base passive immunization therapy for the treatment of atherosclerosis

Country Status (2)

Country Link
CN (1) CN1717251B (en)
SE (1) SE0202959D0 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102711823A (en) * 2009-08-28 2012-10-03 基因泰克公司 Methods of treatment using anti-oxidized LDL antibodies
CA2817548A1 (en) * 2010-11-12 2012-05-18 Cedars-Sinai Medical Center Immunomodulatory compositions, methods and systems comprising immunogenic fragments of apob100

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1206421A (en) * 1995-11-01 1999-01-27 科斯药品公司 Apolipoprotein Ez and treatment of alzheimer's disease
US6225070B1 (en) * 1997-08-07 2001-05-01 The Regents Of The University Of California Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma
NZ531712A (en) * 1999-10-26 2006-03-31 Univ California Reagents and methods for diagnosing, imaging and treating atherosclerotic disease

Also Published As

Publication number Publication date
CN1717251A (en) 2006-01-04
CN1717251B (en) 2011-10-05

Similar Documents

Publication Publication Date Title
HK1087018A1 (en) Peptide-based passive immunization therapy for treatment of atherosclerosis
DE60236646D1 (en) Anti-VEGF-2 antibodies
CY1120070T1 (en) METHOD OF THERAPEUTIC TREATMENT WITH THE USE OF ANTI-ERBB-METHYSINEOID ANTIBODY conjugates
ATE415423T1 (en) IMMUNIZATION THERAPY FOR THE TREATMENT OF ATHEROSCLERosis
BRPI0418745A (en) cell line antibody, pharmaceutical composition, and method of treating cancer in a patient
MA28418B1 (en) ANTIBODY BINDING AN INTERLEUCIN 4 RECEPTOR
HUP9802212A2 (en) Recombinant anti-cd4 antibodies for human therapy
BR0315161A (en) Isolated antibody, isolated polynicleotide, vector, host cell, method of producing an antibody, and, composition
CY1109525T1 (en) HUMANIZED ANTI-ErbB2 ANTIBODIES AND THERAPEUTIC TREATMENT WITH ANTI-ErbB2 ANTIBODIES
CY1109817T1 (en) OLIGO-BETA (1,3) -GLUCAN AND MONOCLONIC ANTIBODIES AGAINST CANCER
NO20045354L (en) Methods for the treatment of angiogenesis, tumor growth and metastasis
DK1411962T3 (en) Pancreatic cancer therapy with monoclonal drug
EA200601386A1 (en) IMMUNE GLOBULINS AGAINST EpCAM ANTIGEN
WO2004030607A3 (en) Peptide-based passive immunization therapy for treatment of atherosclerosis
DE60208534D1 (en) USE OF ANTIBODY AGAINST MAG FOR THE TREATMENT OF ISCHEMIC ATTACKS
SE0202959D0 (en) Peptide-Base passive immunization therapy for the treatment of atherosclerosis